Login
Register
RSS
News
PubMed
Corporate
Trials
Drugs
Careers
Channels
ReportsPopular Biotech News, Healthcare News and Pharma News
BioPortfolio lists our user's most popular news pages for the last 7 days based on search engine activity.
Dr. Oz Show Highlights GCA® Green Coffee Bean Extract from Applied Food Sciences Inc., Proven in Recent Human Study to Lower Body Mass Index and Aid in Weight Management
After a ground breaking study was presented at the American Chemical Society Meeting in San Diego (March 2012) green coffee bean extract is becoming all the buzz in weight management products. With staggering results participants in the study lost an average of 10% of their body weight without changing diet or exercise. This phenomenal green coffee extract GCA® from Applied Food Sciences wa...
Fifteen-Year-Old Creates Non-Invasive Pancreatic Cancer Detection Tool
Jack Andraka, 15, of Crownsville, Md. was awarded first place for his new method to detect pancreatic cancer at this year’s Intel International Science and Engineering Fair, a program of Society for Science & the Public. Based on diabetic test paper, Jack created a simple dip-stick sensor to test blood or urine to determine whether or not a patient h...
What's Wrong with Steven Tyler's Feet (Besides the Toenail Polish)?
By Celebrity Diagnosis In our latest installment of Ailments of Aging Rock Stars, we describe one thing that can happen to your feet after jumping around on stage for decades. On the premier of her new show, Oprah's Next Chapter, Oprah featured Aer...
Fittest Man and Woman on Earth Crowned at the 2011 Reebok|CrossFit Games
After four months of competition, Rich Froning Jr. has been named the Fittest Man on Earth™ and Annie Thorisdottir has been named The Fittest Woman on Earth™ at the 2011 Reebok|CrossFit Games. Froning Jr, from Cookeville, Tennessee, USA, and Thorisdottir, from Kopavogur, Iceland, earned their titles after beating the 50 male and female finalists from t...
Spinal Restoration, Inc. Updates the Progress of the Biostat® System and Ongoing Phase III Clinical Study Following the CBS Sunday Morning Segment “A new hope for back pain sufferers?”
On Sunday May 6, 2012, CBS Sunday Morning presented a story titled “A new hope for back pain sufferers?” that featured Dr. Kevin Pauza, a member of Spinal Restoration’s clinical advisory board, who discussed his use of fibrin sealant injections for the treatment of back pain. The program indirectly referenced Spinal Restoration’s Biostat System and...
2011 Reebok CrossFit Games to Be Broadcast on ESPN2
CrossFit, Inc. is pleased to announce that the 2011 Reebok CrossFit Games will be broadcast as a multi-part series starting Wednesday, September 14, 2011 from 8:00-10:00p.m. Eastern with subsequent episodes broadcast September 21, 2011 and September 28, 2011 from 8:00-10:00p.m. Eastern. The event took place July 29-31 at the Home Depot Center in Carson, Ca...
Biotech Calendar: 2011-12 FDA Drug Approvals
Updated with corrected FDA approval decision date for Roche's melanoma drug Zelboraf. It's Oct. 28, 2011, not Nov. 11, 2011, as previously reported. BOSTON (TheStreet) -- The 2011 FDA drug approval calendar has been updated and extended through the...
TruFocals, the Award Winning Adjustable Focus Eyeglasses, Re-Brands as Superfocus
Superfocus LLC, formerly known as Zoom Focus Eyewear LLC, announced today the new brand campaign for Superfocus, the award winning adjustable focus eyeglasses formerly known as TruFocals. The new name reflects the benefits Superfocus provides to individuals suffering from presbyopia, a natural result of aging in which the eye's crystalline lens beco...
Novartis Migraine Painkiller Excedrin Recalled
A major recall initiative has been launched by Swiss drug manufacturer Novartis. Working alongside the South African Medicines Control Council, the firm is pressing for supplies of Excedrin - a painkiller used by migraine sufferers - to be recalled o...
Mylan launches generic version of Roxicodone tablets
Mylan Inc. announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone Hydrochloride (HCI) tablets USP, 5 mg, 15 mg and 30 mg, based on a development and supply agreement with Coastal Pharmaceuticals.
Tommie Copper's Message of “Pain Relief Without a Pill” Goes Primetime
Tommie Copper’s Compression Wear the Focus of a New Television Show Airing the Week of October 24th Featuring Montel Williams Ossining, NY (PRWEB) October 19, 2011 Tommie Copper, the leader in comfortable compression wear, debuts its full line on national television with Montel Williams beginning October 24th. Tommie Copper’s compression gear harnesses the well-known health benefits of copper...
ADDING MULTIMEDIA Fifteen-Year-Old Creates Non-Invasive Pancreatic Cancer Detection Tool
Jack Andraka, 15, of Crownsville, Md. was awarded first place for his new method to detect pancreatic cancer at this year’s Intel International Science and Engineering Fair, a program of Society for Science & the Public. Based on diabetic test paper, Jack created a simple dip-stick sensor to test blood or urine to determine whether or not a patient h...
DaVita and HealthCare Partners Announce Merger Agreement
DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), and HealthCare Partners, the country’s largest operator of medical groups and physician networks, announced today that they have entered into a definitive merger agreement. The two companies expect to close the transaction ear...
Novartis drops future blockbuster agomelatine
Novartis has stopped development of agomelatine (AGO178) in major depressive disorder. The product had already been approved in the EU (where it is sold by Servier as Valdoxan) and US approval was expected to ensue in 2013, with peak sales of $2.6....
GMP issues affect Mircera, Xenical production at Roche plant
Supply of two Roche products has been disrupted after an active pharmaceutical ingredient (API) production facility in the US was discovered to be out of compliance with Good Manufacturing Practice (GMP). Roche said it has stopped releasing batches o...
Mellow Hope (HTDS) Seminar for Indian Medical Experts to Discuss Cerebroprotein Hydrolysate
SHENZEN, CHINA -- (Marketwire) -- 03/03/11 -- Hard to Treat Diseases, Inc. (PINK SHEETS: HTDS) (www.htdsmedical.com) announced today that its China-based Shenzhen Mellow Hope subsidiary is planning a seminar for Indian medical experts. The Indian experts are expected in China for the seminar and will visit Chinese medical experts in Beijing, Shanghai and Shenzhen. They will discuss plans to mar...
Bond Labs Launches Innovative New Product Stack
Bond Laboratories, Inc. (OTCBB:BNLB), wholly owned operating division, NDS Nutrition Products (“NDS”), today announced the launch of Dual Impact™ Stack into the GNC® franchise system. NDS is a national provider of innovative and proprietary nutritional supplements for health conscious consumers. NDS’ weight loss, general health and sports nutritio...
Express Scripts and Medco to merge in $30 billion deal
Express Scripts (NASDAQ:ESRX) said Thursday that it plans to acquire rival Medco Health Solutions (NYSE:MHS), forming a large new pharmacy benefit management company, in a deal valued at almost $30 billion. Under the terms of the agreement, Exp...
Possible Rivaroxaban Antidote Identified
Researchers in Holland are testing prothrombin complex concentrate's ability to reverse the effects of the new anticoagulants rivaroxaban and dabigatran, which so far lack a proven antidote that can stop a serious bleed or allow coagulation during an...
Jean Pakter, Women’s Health Advocate in New York, Dies at 101
Dr. Jean Pakter
GSA launches new open-access journal, G3: Genes| Genomes | Genetics
(Genetics Society of America) The Genetics Society of America launches G3: Genes|Genomes|Genetics, a new, open-access journal focused on rapid review and publication of high quality foundational research and experimental resources in genetics and gen...
Will Novartis Benefit From Shortage It Created?
Last month, Novartis slowed or discontinued production of various medicines at a plant in Boucherville, Quebec, where most of Canada’s generic injectables are made, after recent FDA inspections found various manufacturing problems (back story). And...
The Brain: Hidden Epidemic: Tapeworms Living Inside People's Brains | DISCOVER
Theodore Nash sees only a few dozen patients a year in his clinic at the National Institutes of Health in Bethesda, Maryland. That’s pretty small as medical practices go, but what his patients lack in number they make up for in the intensity of th...
Cancer Genetics $48m IPO marches on, in spite of cancellation rumours
Rumours of the demise of Cancer Genetics' $48 million planned initial public offering (IPO) have been exaggerated, according to sources close to the matter. The Rutherford, New Jersey firm first revealed its IPO plans in December, and.....
Sam's Club® Announces New Simply Right™ Vitamin Line
BENTONVILLE, Ark., Jan. 24, 2012 /PRNewswire/ -- Sam's Club®, the nation's eighth largest retailer, today announces the exclusive availability of the Simply Right™ line of quality and affordable vitamins. Simply Right™ vitamins and supplements, replacing the Sam's Club Member's Mark line, are part of the overall Simply Right™ brand, dedicated to providing healt...
G-BA agrees with IQWiG on Zytiga, Gilenya, Trajenta
Germany's Federal Joint Committee (G-BA) issued three final assessments on Thursday that were in line with preliminary assessments from the Institute for Quality and Efficiency in Health Care (IQWiG). G-BA said Zytiga abiraterone from Johnson & Johns...
Noven Confirms Filing of Abbreviated New Drug Application for Generic Lidocaine Patch 5%
Noven Pharmaceuticals, Inc. today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lidocaine topical patch 5%. Noven’s lidocaine topical patch 5% is a generic version of Endo Pharmaceuticals’ Lidoderm®. On May 15, 2012, pursuant to the Hatch-...
Un importante avance en la lucha contra la gordura resistente
SOFÍA ANTÍPOLIS, Francia, 7 de julio de 2011 /PRNewswire/ -- Hasta ahora, no existía ningún método científicamente probado para eliminar la gordura que resultaba resistente a la dieta y el ejercicio. "Impacto de una estimulación mecánica LPG® sobre el perfil de expresión de genes y movilización lípida en tejido adiposo gluteofemoral femen...
Pfizer launches biosimilar Rituxan trial
Pfizer Inc. (NYSE:PFE) unveiled details Tuesday of its biosimilar rituximab program, including the start of a Phase I/II trial in rheumatoid arthritis patients comparing the candidate's pharmacokinetics, pharmacodynamics and safety to that of version...
Bernstein Liebhard Partner Jeffrey S. Grand Appointed To Plaintiffs’ Steering Committee In Transvaginal Mesh MDLs
Bernstein Liebhard LLP is pleased to announce that on April 13, 2012 partner Jeffrey S. Grand was appointed to the Plaintiffs’ Steering Committee in four transvaginal mesh MDLs against manufacturers of vaginal mesh implants. New York, New York (PRWEB) April 25, 2012 Bernstein Liebhard LLP is pleased to announce that on April 13, 2012 partner Jeffrey S. Grand was named to the Plaintiffs’ Steer...
MIT's New DRACO Drug Kills 15 Types Of Virus Disease Cells, H1H1
Scientists at MIT are developing a new drug that may fight viruses as effectively as antibiotics like penicillin dispatch bacteria. In lab tests using animal and human cells, the new therapy was effective against 15 viruses, including the common col...
Takeda closes South San Francisco R&D site in California restructuring
Takeda has decided to close a US research site in South San Francisco that was specialising in the discovery of antibody therapeutics, "relocating the most essential antibody and biologics research technologies and staff" to another.....
Prostate Cancer? Why Radical Surgery/Robotic Prostatectomy is NOT For You
CORAL SPRINGS, Fla., May 17, 2012 /PRNewswire/ -- As the world's top urologists begin the 107th Annual AUA Meeting in Atlanta this Friday, one of the nation's top prostate cancer specialists is challenging his colleagues to initiate long term studies to scientifically, objectively and reliably inform patients as to when and how to treat localized prostate cancer. "Many uninformed, vulnerable...
China National Biotech to Raise $1.6 Billion in Hong Kong IPO
China National Biotech Group (CNBG) expects to raise up to 10 billion RMB ($1.6 billion) in a Hong Kong IPO, according to sources. CNBH is one of many subsidiaries of the sprawling state-owned China National Pharmaceutical Group Corp (Sinopharm)....
Pediculosis - louse, lice infestation
Pediculosis — louse infestation — can be traced to prehistory, with the oldest known fossils of louse eggs dating back approximately 10,000 years. Lice are ectoparasites that live on the body, feeding on blood after piercing the skin and injecting saliva, which causes pruritus. The three types of human lice are: • Head lice — Pediculosis capitis • Body...
Mary Ann Liebert launches Brain Connectivity journal
Mary Ann Liebert, Inc. announces the release of a new peer-reviewed journal in an expanding area of systems neuroscience, Brain Connectivity. This timely new journal is positioned to become the premier source of cutting-edge basic and clinical neuros...
ANSM new French agency turns away from ugly regulatory past
In a move that symbolises France's determination to put the Mediator scandal behind it and move on, the government has formally established a new regulatory body agency, the ANSM, or National Agency for Medicines and Health Products. The body had bee...
HighRes Biosolutions unveils world’s first robotic aquarium on Animal Planet’s television series Tanked
HighRes Biosolutions brings its robotics expertise to the world of exotic aquariums on a new episode of Animal Planet’s hit reality television series Tanked. The episode highlights the antics and excitement in designing, building, and deploying a one-of-a-kind robotic aquarium comprised of three tanks that together resemble one of HighRes’ laboratory a...
CJC-1295 Research Peptide of US Peptides Increasingly Used in HGH Studies
Clearwater, FL, March 25, 2011 --(PR.com)-- CJC-1295 (http://www.uspeptides.com) research peptide is a long acting growth hormone release factor (GHRH) peptide that US Peptides LLC, reports is being increasingly used around the world in research studies and clinical trials. Peptides are chains of amino acid residues with remarkable biological functions, ranging from hormonal regulation to antibi...
FDA to review Novo's insulin products, rebuffs rFXIII
Novo Nordisk A/S (CSE:NVO; NYSE:NVO) said FDA accepted for review NDAs for a pair of its insulin products to treat Type I and II diabetes: insulin Degludec and DegludecPlus. The PDUFA date is July 29. Insulin Degludec is a long-acting insulin analog,...
The Men’s Health and Women’s Health Big Book of Sex
Today, Rodale Inc. launched The Men’s Health and Women’s Health Big Book of Sex (Rodale Books: ISBN: 978-1-60529-303-5; February 1, 2011, $27.99, 384 pages) – a comprehensive guide to a healthier and happier sex life. A unique two-in-one book format—one side for men, the other side for women—gives readers answers not just to their own most pressi...
La linea elure Advanced Skin Lightening™ di Syneron vince il premio "BEST OF BEAUTY" della rivista Allure
YOKNEAM, Israele, September 21, 2011 /PRNewswire/ -- - I prodotti della linea elure Advanced Skin Lightening si aggiudicano il prestigioso titolo di "Importante progresso per la bellezza" assegnato dalla rivista Allure per il 2011 Syneron Medical Ltd. (NASDAQ: ELOS), http://www.syneron.com, azienda leader mondiale nel settore dei prodotti e della tecnologia per l'estetica medica, h...
Univision, HolaDoctor and EnvisionRxOptions Partner to Launch Exclusive Prescription Savings Program
Univision Enterprises and HolaDoctor are pleased to announce a partnership with EnvisionRxOptions to launch an exclusive prescription savings program. The UnivisionSalud con HolaDoctor Prescription Savings Card provides another option to manage healthcare costs for the more than 50 million U.S. Hispanics. The program is scheduled to launch in January 2012....
fit2fat2fit.com: Trainer Gets Fat on Purpose to Understand Overweight Struggles
EAGLE MOUNTAIN, Utah, June 28, 2011 /PRNewswire/ -- www.fit2fat2fit.com is a website about Drew Manning's yearlong journey as he goes from fit, to fat on purpose, and back to fit again. Drew is a personal trainer that will stop exercising and live an unrestricted diet for 6 months, and then put himself through his own exercise routines and meal plans to become healthy again. He is curr...
FDA approves Regeneron Eylea injection
Regeneron Pharmaceuticals' Eylea (aflibercept) injection, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD), has earned FDA approval.
Don't Think Aspirin Works for Pain Relief? Bayer Challenges Consumers to Think Again
MORRISTOWN, N.J., April 17, 2012 /PRNewswire/ -- When it comes to pain relief, Americans don't think of aspirin. In fact, in a recent survey of people who use over-the-counter (OTC) pain relievers, only 8 percent of respondents report taking aspirin more often than other OTC pain relievers in the last year[i] – despite clinical evidence proving it to be an effective OTC analgesic.[ii] To enc...
The MedZilla.com Employment Report for May 2012 -- Unemployment Rate Continues to Fall Bringing New Hope to Job Seekers
MedZilla Reports: April saw the unemployment rate continuing to fall, dipping down to nearly eight percent. According to the Bureau of Labor Statistics, 155,000 jobs were added to the economy; 19,000 of those being positions added in Healthcare alone. (bls.gov, 5/4/2012) The industry is expected to increase employment opportunities with over 4.2 million jobs before 2020, according to research from...
Twitter
Linkedin